首页> 外文OA文献 >Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic

【2h】

Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic

机译：与康康宫的现实世界持久与其他生物疾病改性患者的其他皮肤关节炎从另一个生物学切换的患者的抗触发药物相比

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jennie H. Best; Steven C. Vlad; Lenore Tominna; Ibrahim Abbass;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic [J] . Jennie H. Best, Steven C. Vlad, Lenore Tominna, Rheumatology and Therapy . 2020,第2期

机译：与康康宫的现实世界持久与其他生物疾病改性患者的其他皮肤关节炎从另一个生物学切换的患者相比
2. Comparison of Biologic Disease-Modifying Antirheumatic Drug Therapy Persistence Between Biologics Among Rheumatoid Arthritis Patients Switching from Another Biologic [J] . Stephen S. Johnston, Donna McMorrow, Amanda M. Farr, Rheumatology and Therapy . 2015,第1期

机译：类风湿关节炎患者转用另一种生物制剂之间的生物制剂之间的生物疾病改良抗风湿药物治疗持久性的比较
3. Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan- European TOCERRA register collaboration [J] . Lauper Kim, Nordstrom Dan C., Pavelka Karel, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2018,第9期

机译：与TNF抑制剂与TNF抑制剂的比较有效性作为单药治疗或与常规的合成疾病改性抗逆素药物在使用至少一种生物学疾病改性的抗腹性药物后用类风湿性关节炎患者：从泛欧托拉登记协作分析
4. No adverse physiological responses to infrared whole body hyperthermia in patients with rheumatoid arthritis and ankylosing spondylitis compared to healthy subjects. [C] . F.G.J. OOSTERVELD, E. KOOPMAN, J. OLDE SCHOLTENHUIS, Advances in biomedical research . 2010

机译：与健康受试者相比，类风湿性关节炎和强直性脊柱炎患者对红外全身热疗没有不利的生理反应。
5. “Don’t Rock the Boat”: A Qualitative Narrative Study Exploring Rheumatoid Arthritis Patients’ Experience of Illness and Biologics [D] . Rachich, Meagan . 2020

机译：“不要摇滚船”：探索类风湿性关节炎患者的疾病和生物学经验的定性叙事研究
6. Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic [O] . Jennie H. Best, Steven C. Vlad, Lenore Tominna, 2020

机译：类风湿关节炎患者从另一种生物制剂转用托西珠单抗与其他皮下生物疾病改良抗风湿药的现实世界持久性
7. PMS44 COMPARISON OF REAL-WORLD PERSISTENCE OF SUBCUTANEOUSLY ADMINISTERED BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG THERAPIES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS SWITCHING FROM ANOTHER BIOLOGIC [O] . I. Abbass, L. Tominna, J.H. Best 2019

机译：PMS44从另一个生物学转换的类风湿性关节炎患者中皮下给药的生物疾病改性抗逆肿瘤治疗的真实世界持久性的比较

Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic

著录项

引文网络

相似文献

相关主题

期刊订阅